Credit Suisse Picks 7 Aerospace, Defense Stocks To Buy — And 4 To Avoid
Aerospace and defense stocks have been among the handful of investments that have performed well in a very difficult market in 2022.
Huntington Ingalls Industries Wins U.S. Air Force $76.7M Electronic Warfare Research And Analysis Task Order
HII (NYSE:HII) announced that its Mission Technologies division has been awarded a $76.7 million task order by the U.S. Air Force (USAF) to perform research, analysis, test and evaluation that will support and
Credit Suisse Initiates Coverage On Huntington Ingalls Indus with Neutral Rating, Announces Price Target of $245
Credit Suisse analyst Scott Deuschle initiates coverage on Huntington Ingalls Indus (NYSE:HII) with a Neutral rating and announces Price Target of $245.
Wolfe Research Initiates Coverage On Huntington Ingalls Indus with Outperform Rating, Announces Price Target of $315
Wolfe Research analyst Myles Walton initiates coverage on Huntington Ingalls Indus (NYSE:HII) with a Outperform rating and announces Price Target of $315.
HII Announces Mentor-Protégé Joint Venture With Markesman Group To Accelerate Next-Generation Cybersecurity Solutions
MCLEAN, Va., Oct. 10, 2022 (GLOBE NEWSWIRE) -- HII (NYSE:HII) announced today the formation of Tuple, a mentor-protégé joint venture with Markesman Group. Together, HII and Markesman form a unified team to
Ingalls Shipbuilding Successfully Completes Acceptance Trials For Arleigh Burke-Class Guided Missile Destroyer, Lenah Sutcliffe Higbee
PASCAGOULA, Miss., Oct. 07, 2022 (GLOBE NEWSWIRE) -- HII (NYSE:HII) announced today that its Ingalls Shipbuilding division completed acceptance trials for Arleigh Burke-class guided missile destroyer Lenah Sutcliffe Higbee (DDG 123).
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday’s Mid-Day Session
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.